BR112014028280A2 - composições farmacêuticas tópicas compreendendo terbinafina e ureia - Google Patents

composições farmacêuticas tópicas compreendendo terbinafina e ureia

Info

Publication number
BR112014028280A2
BR112014028280A2 BR112014028280A BR112014028280A BR112014028280A2 BR 112014028280 A2 BR112014028280 A2 BR 112014028280A2 BR 112014028280 A BR112014028280 A BR 112014028280A BR 112014028280 A BR112014028280 A BR 112014028280A BR 112014028280 A2 BR112014028280 A2 BR 112014028280A2
Authority
BR
Brazil
Prior art keywords
terbinafine
urea
pharmaceutical compositions
topical pharmaceutical
topical
Prior art date
Application number
BR112014028280A
Other languages
English (en)
Inventor
Willers Christoph
Evers Dirk-Heinrich
Mallwitz Henning
Herbig Michael
Fielhauer Sabine
Gorissen Sascha
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46148606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014028280(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of BR112014028280A2 publication Critical patent/BR112014028280A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112014028280A 2012-05-14 2013-05-13 composições farmacêuticas tópicas compreendendo terbinafina e ureia BR112014028280A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261646650P 2012-05-14 2012-05-14
EP20120003791 EP2664327A1 (en) 2012-05-14 2012-05-14 Topical pharmaceutical compositions comprising terbinafide and urea
PCT/EP2013/059814 WO2013171159A1 (en) 2012-05-14 2013-05-13 Topical pharmaceutical compositions comprising terbinafine and urea

Publications (1)

Publication Number Publication Date
BR112014028280A2 true BR112014028280A2 (pt) 2019-09-24

Family

ID=46148606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014028280A BR112014028280A2 (pt) 2012-05-14 2013-05-13 composições farmacêuticas tópicas compreendendo terbinafina e ureia

Country Status (20)

Country Link
US (1) US20150111971A1 (pt)
EP (2) EP2664327A1 (pt)
JP (1) JP2015516455A (pt)
KR (1) KR20150013162A (pt)
CN (1) CN104302281A (pt)
AR (1) AR091039A1 (pt)
AU (1) AU2013261918A1 (pt)
BR (1) BR112014028280A2 (pt)
CA (1) CA2872210A1 (pt)
CL (1) CL2014003081A1 (pt)
CO (1) CO7131352A2 (pt)
EA (1) EA201492091A1 (pt)
HK (1) HK1202808A1 (pt)
IL (1) IL235241A0 (pt)
MX (1) MX2014013851A (pt)
PH (1) PH12014502512A1 (pt)
SG (1) SG11201407536UA (pt)
TW (1) TW201350107A (pt)
WO (1) WO2013171159A1 (pt)
ZA (1) ZA201407655B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
DK3209319T3 (da) 2014-10-21 2021-10-04 Hexima Ltd En fremgangsmåde til behandling af svampeinfektioner
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
AU2018221880B2 (en) * 2017-02-15 2023-08-17 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
EP3492068A1 (en) 2017-12-01 2019-06-05 NCP NewCare Products GmbH Composition for treating onychomycosis
WO2019214838A1 (en) * 2018-05-09 2019-11-14 Eviderm Institute Ab Use of an alcohol-containing composition for improving the skin barrier function
PL428534A1 (pl) * 2019-01-10 2020-07-13 Biotts Spółka Akcyjna Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna ją zawierająca
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
WO2024038427A1 (en) * 2022-08-17 2024-02-22 Lyotropic Delivery Systems Ltd. Topical delivery of antifungal agents for treating fungal infections
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
WO2011079234A2 (en) * 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation

Also Published As

Publication number Publication date
HK1202808A1 (en) 2015-10-09
TW201350107A (zh) 2013-12-16
AR091039A1 (es) 2014-12-30
US20150111971A1 (en) 2015-04-23
WO2013171159A1 (en) 2013-11-21
EP2664327A1 (en) 2013-11-20
JP2015516455A (ja) 2015-06-11
AU2013261918A1 (en) 2014-11-06
EA201492091A1 (ru) 2015-03-31
CA2872210A1 (en) 2013-11-21
EP2849739A1 (en) 2015-03-25
CN104302281A (zh) 2015-01-21
CO7131352A2 (es) 2014-12-01
SG11201407536UA (en) 2014-12-30
ZA201407655B (en) 2015-06-24
IL235241A0 (en) 2014-12-31
KR20150013162A (ko) 2015-02-04
MX2014013851A (es) 2015-02-12
PH12014502512A1 (en) 2014-12-22
CL2014003081A1 (es) 2015-03-27

Similar Documents

Publication Publication Date Title
IL289759A (en) Formulations for local disinfection and their uses
BR112015002738A2 (pt) composto , e , composição farmacêutica
BR112014028280A2 (pt) composições farmacêuticas tópicas compreendendo terbinafina e ureia
DK2925293T3 (da) Topiske tetracyclinformuleringer, fremstilling og anvendelser deraf
BR112014029403A2 (pt) conjugados, anticorpo e formulação farmacêutica
DK2844222T3 (da) Lægemiddelformulering med forsinket udløsning
BR112014012005A2 (pt) composições, métodos, formulação farmacêutica e artigo
CL2014002051A1 (es) Composiciones plaguicidas y procesos relacionados con dichas composiones
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
BR112015011111A2 (pt) proteína multifuncional e formulação farmacêutica
DK2897594T3 (da) Farmaceutisk sammensætning
DK2809669T3 (da) Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika
CY2200004T2 (el) Σκευασματα δαπτομυκινης και χρησεις αυτων
BR112015007217A2 (pt) compostos e usos do composto
CL2014002951A1 (es) (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel.
ES2969933T3 (es) Formulaciones farmacéuticas tópicas líquidas en nanoemulsión
DK3156060T3 (da) Farmaceutiske sammensætninger og topisk anvendelse deraf
CO7000772A2 (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
BR112015002646A2 (pt) composto e composição farmacêutica
HK1213813A1 (zh) 種含埃克替尼的皮膚外用藥物組合物及其應用
BR112014009501A2 (pt) organogel e com´posição cosmética
BR112014016122A2 (pt) composto, e, composição farmacêutica
BR112014017217A8 (pt) agente e composição farmacêutica
CO6990712A2 (es) Combinación farmacéutica antineuritica y composiciones

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.